Using AMNet to Track Alcohol Use Disorder Treatment Outcomes

Product not yet rated

Includes a Live Event on 03/16/2021 at 4:00 PM (EDT)

  • Register
    • Non-Member - Free!
    • Regular Member - Free!
    • Retired - Free!
    • Early Career Physician - Free!
    • Resident - Free!
    • Student - Free!
    • Associate - Free!
    • ASAM Staff - Free!
    • International Member - Free!
    • Emeritus Member - Free!
    • Provisional Member - Free!
    • Fellow Member - Free!
    • Honorary Member - Free!
    • CRT Member - Free!

image

Using AMNet to Track Alcohol Use Disorder Treatment Outcomes


More than 850 people die from alcohol withdrawal each year and more than 250,000 are treated at emergency departments. This webinar will provide an overview of ASAM’s Alcohol Withdrawal Management Guideline, highlighting updates in the 2020 edition. The webinar will then outline AMNet measures that can be used to track Alcohol Use Disorder treatment outcomes.

AMNET is an Addiction Medicine practice-based research network. Learn more and join the network here.    

Session Information

Date:  Tuesday, March 16, 2021

Time: 4-5pm ET (3pm CT, 2pm MT, 1pm PT)

Speaker(s): 

  • Lewis Nelson, MD, FASAM, FACEP, FACMT
  • Brian Hurley, MD, MBA, DFASAM 

Learning Objectives

By completing this session, you will be able to:

  1. Summarize treatment recommendations in The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management and discuss how they should be used in practice.
  2. Address the gaps in the continuum of care for alcohol use disorder, including withdrawal management and beyond. 
  3. Apply standardized measures using AMNet to track implementation of the guideline and provide measurement-based care over different stages of the treatment trajectory.

Lewis Nelson

MD, FASAM, FACEP, FACMT

Dr. Nelson is Professor and Vice-Chair in the Department of Emergency Medicine at New York University School of Medicine, and an attending physician at both NYU Langone Medical Center and Bellevue Hospital Center. He is the Director of the Fellowship in Medical Toxicology at NYUSOM and the New York City Poison Control Center. He is a Past-President of the American College of Medical Toxicology, former Chair of the FDA Drug Safety and Risk Management Advisory committee, and an editor of the textbook Goldfrank's Toxicologic Emergencies, now in its 10th edition. He organized the NYC Task Force on Opioid Misuse, and participated with the American College of Emergency Physicians Opioid Guideline Writing Panel, a CDC-funded panel of toxicologists and medical examiners to develop guidelines for the classification of opioid-related death, and the CDC Chronic Opioid Therapy Guideline Expert Panel. He continues to research, publish, and speak on the subject of prescription opioid misuse, drugs of abuse, and medication safety.

Dr. Brian Hurley, MD, MBA, DFASAM

Director of Addiction Medicine, Los Angeles County Department of Health Services

Brian Hurley, MD, MBA, DFASAM is an addiction physician and the Director of Addiction Medicine for the Los Angeles County Department of Health Services. As Director-at-Large, Brian currently serves as a board member of ASAM and gives presentations around the world regarding addiction medicine. He co-chairs the Los Angeles County Department of Health Services’ Substance Use Disorders Workgroup and the SafeMedLA Medications for Addiction Treatment Action Team, and is the Clinical Director of the Treatment Starts Here program through the Center for Clinical Innovation, focused on increasing the delivery of medications for addiction treatment in California’s community health centers. He is a senior researcher at the Friends Research Institute and is a primary investigator on a Tobacco Related Disease Prevention Program-funded project integrating smoking cessation services into community mental health centers and patient-centered medical homes and is the grant lead for three Medications for Addiction Treatment Access Points projects funded by the Sierra Health Foundation supporting access to medications for addiction treatment across Los Angeles County. He is also a co-investigator for several Rand Corporation projects evaluating the integration of substance use disorder treatment within community mental health and Federally Qualified Health Center settings. He also serves on the American Board of Psychiatry and Neurology’s Addiction Psychiatry Examination Writing Committee. Brian completed the Robert Wood Johnson Foundation Clinical Scholars Program at the University of California, Los Angeles (UCLA) and is an alumnus of the Massachusetts General Hospital and McLean Hospital Psychiatry Residency Training Program and the New York University Addiction Psychiatry Fellowship. Additionally, he has served in various roles for the Massachusetts Society of Addiction Medicine, New York Society of Addiction Medicine, and California Society of Addiction Medicine.

Credits and Disclosures


ACCME Accredited with Commendation

ACCME Accreditation Statement

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Society of Addiction Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Board for Certified Counselors ACEP

The American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. The American Society of Addiction Medicine is solely responsible for all aspects of the programs.

NAADAC, the Association for Addiction Professionals

This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1222

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1222

Continuing Education Credits (CEUs)

Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Maintenance of Certification


American Board of Preventive Medicine (ABPM)

The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credits towards ABPM MOC Part II requirements.

American Board of Anesthesiology (ABA)

This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

American Board of Pediatrics (ABP)

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

American Board of Internal Medicine (ABIM)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

American Board of Surgery (ABS)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit

American Board of Psychiatry and Neurology (ABPN)

Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

American Board of Addiction Medicine (ABAM)

Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

CME Reviewer and Disclosure Information


ASAM CME Committee Reviewer

Subhadeep Barman, MD, FASAM, FAPA – No Relevant Financial Disclosures

Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

Faculty and Planning Committee


Faculty Disclosure Information

Lewis Nelson, MD, FASAM, FACEP, FACMT - No Relevant Financial Disclosures

Brian Hurley, MD, MBA, DFASAM - No Relevant Financial Disclosures


Planning Committee Disclosure Information

Frank Vocci, PhD – Does Disclose

  • Cardiol Therapeutics, Clinical Condition: OUD, Consultant/Advisory Board, Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support), Cardiol would supply CBD for a clinical trial funded by NIDA
  • Braeburn Pharma, Clinical Condition OUD, Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support), If other, please describe: receipt of drug for a clinical trial
  • Lyndra Pharma, Clinical Condition, OUD, Consultant/Advisory Board

Anna Pagano, PhD – No Relevant Financial Disclosures

Lewis Nelson, MD, FASAM, FACEP, FACMT - No Relevant Financial Disclosures

Key:

Complete
Failed
Available
Locked
Using AMNet to Track Alcohol Use Disorder Treatment Outcomes
03/16/2021 at 4:00 PM (EDT)   |  60 minutes
03/16/2021 at 4:00 PM (EDT)   |  60 minutes This webinar outlines the highlights of ASAM's Alcohol Withdrawal Management Guideline as well as the AMNet measures that can be used to track Alcohol Use Disorder treatment outcomes.
CME Evaluation
17 Questions
17 Questions Please complete the evaluation to claim CME.
Credit and Certificate
Up to 1.00 medical credits available  |  Certificate available
Up to 1.00 medical credits available  |  Certificate available This webinar has been approved for 1 AMA PRA Category 1 Credit.